ASCO ANNUAL MEETING News, Sports, Shopping, Travel information

Asco Annual Meeting
Shop for Asco Annual Meeting, and deals on tons of other products at MonsterMarketplace.
www.monstermarketplace.com

New Data Will Be Presented At Ash On Velcade(r) (bortezomib) For Injection-based Therapies In Multiple Myeloma And ...
millennium: the takeda oncology company today announced that 120 data presentations concerning velcade research will be featured at the 50th american society of hematology annual meeting in san francisco, california, december 5-9, 2008.
biz.yahoo.com

New Data Will Be Presented At Ash On Velcade(r) (bortezomib) For ... - Biloxi Sun Herald
cambridge, mass., nov. 18 /prnewswire/ -- millennium: the takeda oncology company today announced that 120 data presentations concerning velcade research will be featured at the 50th american society of hematology (ash) annual meeting in san ...
www.sunherald.com

Cell Genesys, Inc. Q3 2008 Earnings Call Transcript - Seekingalpha.com
ladies and gentlemen, thank you for standing by, and welcome to the cell genesys third quarter 2008 conference call. at this time, all participants are in a listen-only mode. later we will conduct a question-and-answer session with instructions being ...
seekingalpha.com

Asco Winners & Losers - Cnbc
here are some of the more notorious prostitution scandals that have made their way into the headlines over the years. [ onxx   loading...       ( )   ] was the big winner at the annual meeting of the american society of clinical oncology , or ...
www.cnbc.com

Asco: 'open Door Policy' Levels Playing Field - Cnbc
companies: imclone systems inc. thestreet.com's senior biotech writer adam feuerstein broke this story earlier today , but now we've confirmed it independently. the american society of clinical oncology (asco) is changing its ways. the organization ...
www.cnbc.com

Rosetta Genomics To Present At The Upcoming Eortc-nci-asco Annual ... - Pr Newswire
rehovot, israel and jersey city, new jersey, october 23 /prnewswire/ -- rosetta genomics ltd. (nasdaq: rosg) , a leader in the development of microrna-based diagnostics and therapeutics, today announced that it will present at the upcoming eortc-nci ...
sev.prnewswire.com

Ardea Biosciences To Present Clinical Data On Its Lead Mek Inhibitor ... - Phramalive.com
rdea119, a non-atp competitive, highly-selective mek inhibitor in development for the treatment of cancer, is the company's lead compound from its mek inhibitor research and development program. rdea119 has shown potential as a potent inhibitor of ...
www.pharmalive.com

New Eloxatin(r) And Taxotere(r) Data In Several Tumor Types To Be ... - Pr Newswire
- 430 abstracts from studies involving taxotere(r) or eloxatin(r) accepted at the meeting's scientific sessions - bridgewater, n.j., may 31 /prnewswire-firstcall/ -- sanofi-aventis u.s. announced today that key study results from the company's ...
www.prnewswire.com

Ardea Biosciences Inc. (rdea) - Wall Street Journal
oct. 29 ardea biosciences to present at the oppenheimer 19th annual healthcare conference and the lazard capital markets 5th annual healthcare conference oct. 27 ardea biosciences presents preliminary data from a phase 1 study of rdea594 at the 2008 ...
online.wsj.com

Tests Could Predict Benefit From Cancer Drugs - Washington Post
resize wednesday, oct. 29 (healthday news) -- what if a blood test or biopsy could predict if a cancer therapy will help cure you, or only make you feel worse? tests like these, based on genes, proteins or other "molecular markers" may someday do ...
www.washingtonpost.com

Folfox4 (eloxatin(r)-based Chemotherapy) After Surgery Improves ... - Pr Newswire
survival analysis (6-year median follow-up) of the mosaic study presented at this year's asco chicago, june 3 /prnewswire-firstcall/ -- folfox4, an eloxatin(r) (oxaliplatin injection)-based chemotherapy regimen, significantly improved the overall ...
www.prnewswire.com